SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Zaramella Luca

(Last) (First) (Middle)
MONDELEZ INTERNATIONAL, INC.
THREE PARKWAY NORTH

(Street)
DEERFIELD IL 60015

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2018
3. Issuer Name and Ticker or Trading Symbol
Mondelez International, Inc. [ MDLZ ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP & Chief Financial Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock 65,561(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy) (2) 02/23/2021 Class A Common Stock 13,100 20.8303 D
Stock Options (right to buy) (3) 02/23/2022 Class A Common Stock 16,580 24.8687 D
Stock Options (right to buy) (4) 02/20/2023 Class A Common Stock 27,730 27.05 D
Stock Options (right to buy) (5) 02/19/2024 Class A Common Stock 21,960 34.165 D
Stock Options (right to buy) (6) 02/18/2025 Class A Common Stock 25,380 36.94 D
Stock Options (right to buy) (7) 02/22/2026 Class A Common Stock 24,410 39.7 D
Stock Options (right to buy) (8) 02/16/2027 Class A Common Stock 22,570 43.2 D
Stock Options (right to buy) (9) 02/22/2028 Class A Common Stock 22,410 43.51 D
Explanation of Responses:
1. Total number of shares includes 24,070 deferred stock units awarded under the Issuer's Amended and Restated 2005 Performance Incentive Plan. Deferred stock units will vest on October 16, 2020.
2. Options vested in three annual installments as follows: 33% on February 23, 2012; 33% on February 25, 2013; and 34% on February 24, 2014.
3. Options vested in three annual installments as follows: 33% on February 23, 2013; 33% on February 23, 2014; and 34% on February 23, 2015.
4. Options vested in three annual installments as follows: 33% on February 20, 2014; 33% on February 20, 2015; and 34% on February 20, 2016.
5. Options vested in three annual installments as follows: 33% on February 19, 2015; 33% on February 19, 2016; and 34% on February 19, 2017.
6. Options vested in three annual installments as follows: 33% on February 18, 2016; 33% on February 18, 2017; and 34% on February 18, 2018.
7. Options vested or will vest in three annual installments as follows: 33% on February 22, 2017; 33% on February 22, 2018; and 34% on February 22, 2019.
8. Options vested or will vest in three annual installments as follows: 33% on February 16, 2018; 33% on February 16, 2019; and 34% on February 16, 2020.
9. Options will vest in three annual installments as follows: 33% on February 22, 2019; 33% on February 22, 2020; and 34% on February 22, 2021.
Remarks:
Exhibit 24.1 Power of Attorney
/s/ Jenny L. Lauth, by Power of Attorney 08/01/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints
each of Jonathan W. 
Harris, Jenny L. Lauth and Carol J. Ward, signing singly, the undersigned's true
and lawful attorney-in-
fact to:
(1)	prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to 
the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including 
amendments thereto, and any other documents necessary or appropriate to obtain
codes and 
passwords enabling the undersigned to make electronic filings with the SEC of
reports 
required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or
regulation of 
the SEC;
(2)	execute for and on behalf of the undersigned, in the undersigned's capacity
as an executive 
officer of Mondelez International, Inc. (the "Company"), Forms 3, 4 and 5 in
accordance with 
Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; 
(3)	do and perform any and all acts for and on behalf of the undersigned which
may be necessary 
or desirable to complete and execute any such Form 3, 4 or 5, complete and
execute any 
amendment or amendments thereto, and timely file such form with the SEC and any
stock 
exchange or similar authority; and  
(4)	take
 any other action of any type whatsoever in connection with the
foregoing which, in the 
opinion of such attorney-in-fact, may be of benefit to, in the best interest of,
or legally 
required by, the undersigned, it being understood that the documents executed by
such 
attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney
shall be in 
such form and shall contain such terms and conditions as such attorney-in-fact
may approve 
in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform 
any and every act and thing whatsoever requisite, necessary, or proper to be
done in the exercise of any of 
the rights and powers herein granted, as fully to all intents and purposes as
the undersigned might or 
could do if personally present, with full power of substitution or revocation,
hereby ratifying and 
confirming all that such attorney-in-fact, or such attorney-in-fact's substitute
or substitutes, shall lawfully 
do or cause to be done by virtue of this Power of Attorney and the rights and
powers herein granted. The 
undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request 
of the undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's 
responsibilities to comply with Section 16 of the Securities Exchange Act of
1934. 
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to 
file Forms 3, 4 and 5 with respect to the undersigned's holdings of and
transactions in securities issued by 
the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing 
attorneys-in-fact. 
This Power of Attorney revokes all prior Powers of Attorney relating to
reporting under Section 16 of the 
Securities Exchange Act of 1934 of the Company's securities and shall remain in
effect until revoked by a 
subsequently filed instrument.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 
25th day of June, 2018.

/s/ Luca Zaramella
Signature
Luca Zaramella
Print Name